The veterinary medicine market involves products used for the prevention, diagnosis, and treatment of animal diseases. Veterinary medicines include vaccines, parasiticides, anti-infectives, medications for pain and inflammation, and other pharmaceuticals. The growing pet population worldwide has significantly increased the demand for pet care products including veterinary drugs for pets like dogs and cats. According to estimates, the global pet population exceeded 900 million in 2018, with cats and dogs accounting for over 90% of pet animals. Rising awareness about animal health among pet owners and growing per capita expenditures on pet care are driving the growth of the veterinary medicine industry.

The Global veterinary medicine market is estimated to be valued at US$ 39.27 Bn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the veterinary medicine market are BASF SE, BP Plc., China Petroleum & Chemical Corporation, ExxonMobil Corporation, IRPC Plc., and LyondellBasell Industries Holdings B.V. Major pharmaceutical companies in this space include Zoetis, Inc., Boehringer Ingelheim GmbH, Elanco Animal Health, and Bayer AG.

The pet care industry is witnessing notable growth opportunities such as increasing spending on companion animal health in emerging countries. Additionally, rising animal agriculture and growing meat consumption point towards demand generation from food animals over the forecast period.

Global expansion is another key trend with major pharmaceutical players actively pursuing business expansion strategies in high growth regions. For instance, Zoetis expanded its operations in China through acquisitions and invested in manufacturing facilities in countries like Brazil and India. Elanco also augmented its global footprint through strategic acquisitions.

Market Drivers
- Rising pet population worldwide: According to estimates, there are over 350 million pet dogs and 150 million pet cats globally. Increasing pet adoption rates necessitate higher spending on pet healthcare including Veterinary Medicines Market
- Growing per capita expenditure on pet care: Pet owners are willing to spend increasingly higher amounts on pet food, healthcare, insurance, and other services. This bodes well for veterinary pharmaceutical manufacturers.

Market Restraints
- Stringent regulations: Veterinary drugs face stringent approval processes owing to factors like safety evaluation of residues in food-producing animals. This results in longer development cycles and higher costs.
- Threat from generic drugs: Expiry of major patents makes veterinary pharmaceuticals susceptible to competition from cheaper generic counterparts. This squeezes profit margins for innovator companies.

Segment Analysis
The veterinary medicine market is dominated by the small companion animal segment, which accounts for over 50% of the overall market share. Being more affordable and accessible, medicines and therapeutic products for pets like dogs and cats see higher consumption. Their growing adoption as companions across households globally has significantly boosted demand for pet care products, including pharmaceuticals. For instance, in the US alone, about 67% of households owned a pet in 2020. Within this segment, dermatology drugs are the fastest growing sub-segment owing to the rising prevalence of skin allergies and infections in pets. The increasing pet health expenditure and growing awareness among owners regarding animal wellness are strengthening the growth of this sub-segment.

Global Analysis
The North American region currently holds the largest share in the global veterinary medicine market due to rising companion pet adoption, growing per capita pet care spending, and advanced veterinary infrastructure. However, the Asia Pacific region is emerging as the fastest-growing market on account of increasing livestock population, improved animal welfare regulations, and growing pet ownership in countries like India and China. Latin America and Middle East & Africa also present lucrative opportunities for market players owing to the burgeoning veterinary services sector and rising meat consumption in these regions. Various initiatives promoting animal healthcare by international organizations are further supporting the regional expansion of global industry players.


Get More Insights On Veterinary Medicine Market